Discovery and Initial SAR of Arylsulfonylpiperazine Inhibitors of 11beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1)
Sun, D., Wang, Z., Di, Y., Jaen, J.C., Labelle, M., Ma, J., Miao, S., Sudom, A., Tang, L., Tomooka, C.S., Tu, H., Ursu, S., Walker, N., Yan, X., Ye, Q., Powers, J.P.(2008) Bioorg Med Chem Lett 18: 3513-3516
- PubMed: 18511278 
- DOI: https://doi.org/10.1016/j.bmcl.2008.05.025
- Primary Citation of Related Structures:  
3CZR - PubMed Abstract: 
High-throughput screening of a small-molecule compound library resulted in the identification of a series of arylsulfonylpiperazines that are potent and selective inhibitors of human 11beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1). Optimization of the initial lead resulted in the discovery of compound (R)-45 (11beta-HSD1 IC(50)=3nM).
Organizational Affiliation: 
Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA. [email protected]